BioSenic S.A.
BIOS.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | -100% | 83.4% | -5.1% | – |
| Gross Profit | -€0 | €0 | €0 | €0 |
| % Margin | – | 100% | 100% | 316.3% |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | – | -1,251.6% | -762.8% | -276.9% |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | – | -5,299.8% | -689.5% | -315.4% |
| EPS Diluted | -0.021 | -0.21 | -0.017 | -0.046 |
| % Growth | 90.2% | -1,135.3% | 63.2% | – |
| Operating Cash Flow | -€0 | -€0 | -€0 | -€0 |
| Capital Expenditures | €0 | €0 | -€0 | -€0 |
| Free Cash Flow | €0 | -€0 | -€0 | -€0 |